Distribution of Transmission Potential During Nonsevere COVID-19 Illness

Nabin K Shrestha, Francisco Marco Canosa, Amy S Nowacki, Gary W Procop, Sherilynn Vogel, Thomas G Fraser, Serpil C Erzurum, Paul Terpeluk, Steven M Gordon, Nabin K Shrestha, Francisco Marco Canosa, Amy S Nowacki, Gary W Procop, Sherilynn Vogel, Thomas G Fraser, Serpil C Erzurum, Paul Terpeluk, Steven M Gordon

Abstract

Background: Patients recovering from coronavirus disease 2019 (COVID-19) often continue to test positive for the causative virus by polymerase chain reaction (PCR) even after clinical recovery, thereby complicating return-to-work plans. The purpose of this study was to evaluate transmission potential of COVID-19 by examining viral load with respect to time.

Methods: Health care personnel (HCP) at Cleveland Clinic diagnosed with COVID-19, who recovered without needing hospitalization, were identified. Threshold cycles (Ct) for positive PCR tests were obtained and viral loads calculated. The association of viral load with days since symptom onset was examined in a multivariable regression model, which was reduced by stepwise backward selection to only keep variables significant at a level of .05. Viral loads by day since symptom onset were predicted using the model and transmission potential evaluated by examination of a viral load-time curve.

Results: Over 6 weeks, 230 HCP had 528 tests performed. Viral loads declined by orders of magnitude within a few days of symptom onset. The only variable significantly associated with viral load was time since onset of symptoms. Of the area under the curve (AUC) spanning symptom onset to 30 days, 96.9% lay within the first 7 days, and 99.7% within 10 days. Findings were very similar when validated using split-sample and 10-fold cross-validation.

Conclusions: Among patients with nonsevere COVID-19, viral loads in upper respiratory specimens peak by 2 or 3 days from symptom onset and decrease rapidly thereafter. The vast majority of the viral load-time AUC lies within 10 days of symptom onset.

Keywords: SARS virus; area under curve; disease transmission; infectious; viral load.

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Figures

Figure 1.
Figure 1.
Scatterplot of viral load versus days since onset of symptoms. Points on the scatterplot represent individual tests. The y-axis is on a logarithmic scale. Viral load is represented as number of times the minimum detectable viral load. Negative tests are assigned a viral load of 1 to avoid a log(0) error. The shape of each point corresponds to the gender of the patient tested. Points are jittered along the x-axis to unmask overlap.
Figure 2.
Figure 2.
Relationship between days since onset of symptoms and the log10 viral load in a restricted cubic splines regression model with 4 degrees of freedom. The boxplots show the distribution of the log10 of the actual viral load each day after onset of symptoms. Viral load is represented as number of times the minimum detectable viral load. The black circles and fitted line represent the predicted log10 viral loads for each day.
Figure 3.
Figure 3.
Viral load-time curve showing the proportion of the 30-day AUC that lies within various intervals. Viral loads were predicted from the final restricted cubic spline regression model. The predicted viral load for each day was plotted against days since onset of symptoms. Viral load is represented as number of times the minimum detectable viral load. The area under the viral load-time curve was calculated by integration of the function representing the relationship between the predicted viral load and days since onset of symptoms. Abbreviations: d, days; AUC, area under the curve.

References

    1. Burrer SL, de Perio MA, Hughes MM, et al. . Characteristics of health care personnel with COVID-19—United States, February 12–April 9, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:477–81.
    1. Centers for Disease Control and Prevention. Return-to-work criteria for healthcare workers 2020. Available at: . Accessed 1 May 2020.
    1. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2020.
    1. Kowarik A, Templ M. Imputation with the {R} Package {VIM}. J Stat Softw 2016; 74:1–16.
    1. van Buuren S, Groothuis-Oudshoorn K. {mice}: multivariate imputation by chained equations in R. J Stat Softw 2011; 45:1–67.
    1. Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag, 2016.
    1. To KKW, Tsang OTY, Leung WS, et al. . Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20:565–74.
    1. Tu Y-P, Jennings R, Hart B, et al. . Swabs collected by patients or health care workers for SARS-CoV-2 testing. N Engl J Med 2020. Published online 3 June 2020. doi:10.1056/NEJMc2016321.
    1. Almocera AES, Nguyen VK, Hernandez-Vargas EA. Multiscale model within-host and between-host for viral infectious diseases. J Math Biol 2018; 77:1035–57.
    1. Quinn TC, Wawer MJ, Sewankambo N, et al. . Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921–9.
    1. Mayer BT, Krantz EM, Wald A, et al. . Estimating the risk of human herpesvirus 6 and cytomegalovirus transmission to Ugandan infants from viral shedding in saliva by household contacts. Viruses 2020; 12:171.
    1. Arons MM, Hatfield KM, Reddy SC, et al. ; Public Health–Seattle and King County and CDC COVID-19 Investigation Team Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med 2020; 382:2081–90.
    1. Wölfel R, Corman VM, Guggemos W, et al. . Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581:465–9.
    1. Sakurai A, Sasaki T, Kato S, et al. . Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med 2020. Published online 12 June 2020. doi:10.1056/NEJMc2013020.
    1. He X, Lau EHY, Wu P, et al. . Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020; 26:672–5.
    1. Zou L, Ruan F, Huang M, et al. . SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382:1177–9.
    1. Bullard J, Dust K, Funk D, et al. . Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis 2020. Published online 22 May 2020. doi:10.1093/cid/ciaa638.
    1. Cheng H-Y, Jian S-W, Liu D-P, et al. . Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. Published online 1 May 2020. doi:10.1001/jamainternmed.2020.2020.
    1. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2—Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:411–5.
    1. Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054–62.

Source: PubMed

3
Sottoscrivi